Clonal dominance of CD133(+) subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma

por SHARMA, BHUVNESH K., MANGLIK, V., O’CONNELL, MICHAEL, WEERARATNA, ASHANI, McCARRON, EDWARD C., BROUSSARD, JENNIFER N., DiVITO, KYLE A., SIMBULAN-ROSENTHAL, CYNTHIA M., ROSENTHAL, DEAN S., ZAPAS, JOHN L.
Publicado 2012

The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRAS(Q61K) melanoma

por Simbulan-Rosenthal, Cynthia M., Dakshanamurthy, Sivanesan, Gaur, Anirudh, Chen, You-Shin, Fang, Hong-Bin, Abdussamad, Maryam, Zhou, Hengbo, Zapas, John, Calvert, Valerie, Petricoin, Emanuel F., Atkins, Michael B., Byers, Stephen W., Rosenthal, Dean S.
Publicado 2017